Brain FDG‐PET findings in chimeric antigen receptor T‐cell therapy neurotoxicity for diffuse large B‐cell lymphoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain FDG‐PET findings in chimeric antigen receptor T‐cell therapy neurotoxicity for diffuse large B‐cell lymphoma
Authors
Keywords
-
Journal
JOURNAL OF NEUROIMAGING
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-06-09
DOI
10.1111/jon.13135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study
- (2023) Umberto Pensato et al. JOURNAL OF NEUROLOGY
- Lymphoma pseudoprogression observed on [18F]FDG PET-CT scan 15 days after CAR-T infusion
- (2022) Dan Cohen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Day 30 SUVmax Predicts Progression in Lymphoma Patients Achieving PR/SD After CAR T-cell Therapy
- (2022) Ajlan Al Zaki et al. Blood Advances
- Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT
- (2022) William G. Breen et al. Journal of Hematology & Oncology
- PET-imaging assessment for guiding strategy in patients with relapsed/refractory large B-cell lymphoma receiving CAR T-cells
- (2022) Jean Galtier et al. HAEMATOLOGICA
- The role of neurologists in the era of cancer immunotherapy: Focus on CAR T-cell therapy and immune checkpoint inhibitors
- (2022) Umberto Pensato et al. Frontiers in Neurology
- Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy
- (2022) Anna Guidetti et al. CANCER
- Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
- (2022) Therese Sjöholm et al. CANCER IMAGING
- SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses
- (2021) Andrea Pilotto et al. CLINICAL INFECTIOUS DISEASES
- Brain dysfunction in COVID‐19 and CAR‐T therapy: cytokine storm‐associated encephalopathy
- (2021) Umberto Pensato et al. Annals of Clinical and Translational Neurology
- From early limbic inflammation to long COVID sequelae
- (2021) Eric Guedj et al. BRAIN
- In vivo mechanisms of cortical network dysfunction induced by systemic inflammation
- (2021) Karin Odoj et al. BRAIN BEHAVIOR AND IMMUNITY
- [18F]FDG PET-CT in patients with DLBCL treated with CAR-T cell therapy: a practical approach of reporting pre- and post-treatment studies
- (2021) Dan Cohen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS
- (2021) Andrea Paccagnella et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
- (2021) Umberto Pensato et al. JOURNAL OF NEUROLOGY
- EEG findings in CAR T-cell-associated neurotoxicity: Clinical and radiological correlations
- (2021) Isabelle Beuchat et al. NEURO-ONCOLOGY
- Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma
- (2021) Ruimin Hong et al. Frontiers in Oncology
- EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3
- (2021) Eric Guedj et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging-based Toxicity and Response Pattern Assessment Following CAR T-Cell Therapy
- (2021) Daniel A. Smith et al. RADIOLOGY
- Covid‐19‐associated encephalopathy and cytokine‐mediated neuroinflammation
- (2020) Lorenzo Muccioli et al. ANNALS OF NEUROLOGY
- 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?
- (2020) E Guedj et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma
- (2020) Erin A. Dean et al. Blood Advances
- Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19
- (2020) P. Perrin et al. EUROPEAN JOURNAL OF NEUROLOGY
- Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma
- (2020) Paolo Strati et al. Blood Advances
- Neurological toxicities associated with chimeric antigen receptor T-cell therapy
- (2019) Daniel B Rubin et al. BRAIN
- Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma
- (2019) Jiasheng Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy
- (2019) Huiwen Jiang et al. ANNALS OF HEMATOLOGY
- Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment
- (2019) Jessica Rice et al. Current Treatment Options in Neurology
- Management of the Critically Ill Adult Chimeric Antigen Receptor-T Cell Therapy Patient
- (2018) Cristina Gutierrez et al. CRITICAL CARE MEDICINE
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- Neurotoxicity after CTL019 in a Pediatric and Young Adult Cohort
- (2018) Jacqueline S. Gofshteyn et al. ANNALS OF NEUROLOGY
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
- (2017) Silvia Morbelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
- (2016) D. T. Teachey et al. Cancer Discovery
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Regional Susceptibility to TNF-α Induction of Murine Brain Inflammation via Classical IKK/NF-κB Signalling
- (2012) Adam M. H. Young et al. PLoS One
- Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study
- (2009) Silvia Morbelli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Type I and Type II error concerns in fMRI research: re-balancing the scale
- (2009) Matthew D. Lieberman et al. Social Cognitive and Affective Neuroscience
- Differential Frontal Activation during Exogenous and Endogenous Orientation of Visuospatial Attention
- (2008) Masaharu Takahashi et al. NEUROPSYCHOBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now